13th Jan 2022 12:27
(Alliance News) - Oxford Nanopore Technologies PLC announced on Thursday it had worked with a team led by Stanford University School of Medicine in research to develop a rapid genome sequencing approach.
The Oxford-based company focused on developing nanopore sequencing products said that the research will improve prognosis in critically ill patients, reduce the time to identify disease-causing genetic variants and provides the potential to identify large and complex disease-causing variants that were missed by previous approaches.
Nanopore sequencing is a technology that enables the real-time analysis of long DNA or RNA fragments. It works by monitoring changes to an electrical current as nucleic acids are passed through a protein nanopore. The resulting signal is decoded to provide the specific DNA or RNA sequence.
Oxford Nanopore said it had worked with a research team including Nvidia Corp and Alphabet Inc's Google among others to develop a whole genome nanopore sequencing approach that can characterise pathogenic variants in as little as 7 hours and 18 minutes. Oxford Nanopore said this was faster than any previously published approach.
Shares in Oxford Nanopore were up 2.6% at 568.28 pence on Thursday in London.
By Heather Rydings; [email protected]
Copyright 2022 Alliance News Limited. All Rights Reserved.
Related Shares:
Oxford Nano